Perrigo Co. (NYSE:PRGO) Director Geoffrey M. Parker bought 2,500 shares of the company’s stock in a transaction dated Monday, November 21st. The stock was bought at an average cost of $88.75 per share, with a total value of $221,875.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Perrigo (NYSE:PRGO) last released its quarterly earnings data on Thursday, November 10th. The company reported $1.65 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.58 by $0.07. The firm had revenue of $1.40 billion for the quarter, compared to analyst estimates of $1.28 billion. Perrigo had a positive return on equity of 10.78% and a negative net margin of 26.62%. The business’s revenue for the quarter was up .8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.76 earnings per share.

Insider Buying and Selling by Quarter for Perrigo (NYSE:PRGO)

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 13th. Stockholders of record on Friday, November 25th will be given a $0.145 dividend. This represents a $0.58 annualized dividend and a dividend yield of 0.66%. The ex-dividend date is Tuesday, November 22nd. Perrigo’s payout ratio is -5.53%.

Several institutional investors have recently bought and sold shares of PRGO. Parnassus Investments CA increased its position in Perrigo by 53.7% in the second quarter. Parnassus Investments CA now owns 5,498,887 shares of the company’s stock valued at $498,584,000 after buying an additional 1,922,347 shares during the last quarter. Brown Brothers Harriman & Co. increased its position in Perrigo by 13.0% in the third quarter. Brown Brothers Harriman & Co. now owns 4,841,742 shares of the company’s stock valued at $447,038,000 after buying an additional 557,155 shares during the last quarter. BlackRock Institutional Trust Company N.A. increased its position in Perrigo by 2.1% in the third quarter. BlackRock Institutional Trust Company N.A. now owns 3,702,709 shares of the company’s stock valued at $341,871,000 after buying an additional 76,809 shares during the last quarter. Scopia Capital Management LP purchased a new position in Perrigo during the third quarter valued at approximately $279,068,000. Finally, Franklin Resources Inc. increased its position in Perrigo by 1.3% in the second quarter. Franklin Resources Inc. now owns 2,661,431 shares of the company’s stock valued at $241,311,000 after buying an additional 33,921 shares during the last quarter. 65.78% of the stock is currently owned by institutional investors.

A number of brokerages have recently issued reports on PRGO. Leerink Swann set a $81.00 target price on Perrigo and gave the stock a “hold” rating in a report on Wednesday, August 10th. Vetr cut Perrigo from a “buy” rating to a “hold” rating and set a $98.60 target price for the company. in a report on Tuesday, August 9th. RBC Capital Markets set a $92.00 target price on Perrigo and gave the stock a “hold” rating in a report on Monday, October 24th. Deutsche Bank AG reissued a “buy” rating and issued a $105.00 target price on shares of Perrigo in a report on Tuesday, September 13th. Finally, Guggenheim set a $125.00 target price on Perrigo and gave the stock a “buy” rating in a report on Thursday, September 15th. One equities research analyst has rated the stock with a sell rating, sixteen have issued a hold rating and four have given a buy rating to the company. Perrigo presently has a consensus rating of “Hold” and a consensus target price of $109.45.

COPYRIGHT VIOLATION WARNING: “Geoffrey M. Parker Buys 2,500 Shares of Perrigo Co. (PRGO) Stock” was first posted by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are reading this article on another domain, it was stolen and reposted in violation of U.S. & international trademark & copyright legislation. The correct version of this article can be read at https://www.thecerbatgem.com/2016/11/23/geoffrey-m-parker-buys-2500-shares-of-perrigo-co-prgo-stock.html.

About Perrigo

Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.

5 Day Chart for NYSE:PRGO

Receive News & Stock Ratings for Perrigo Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo Co. and related stocks with our FREE daily email newsletter.